Cantourage is a leading European medical cannabis provider. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffman. Cantourage empowers producers from around the globe to introduce their products to the growing and profitable European market faster and more cost-effectively – while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, dronabinol and pharmaceutical-grade cannabidiol.